Increased β-amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutation
Abstract
Cell lines transfected with the Swedish Alzheimer's disease amyloid precursor protein APP670/671 mutation release significantly more β-amyloid than wild-type cells. Citron et al. [Proc. Natl. Acad. Sci. USA (1994) in press] have recently shown that fibroblasts carrying the APP670/671 mutation also release more β-amyloid than control cells [1]. The present study confirms a ca. threefold increase in β-amyloid release from mutation-bearing fibroblasts. APP mRNA levels did not differ between mutation-bearing and control cells, although mutation-bearing fibroblasts contained significantly more APP751/770 than controls. Mild stress decreased β-amyloid secretion and increased APP751/770 levels in all cell lines. In conclusion, the proportion of APP committed to amyloidogenic processing is increased in fibroblasts from family members with the APP670/671 mutation, and this mutation may also compromise the APP stress response.
- Publication:
-
FEBS Letters
- Pub Date:
- January 1994
- DOI:
- Bibcode:
- 1994FEBSL.354..274J
- Keywords:
-
- Alzheimer's disease;
- Amyloid precursor protein;
- APP mRNA;
- β-Amyloid;
- Fibroblast;
- Foetal calf serum